Archives

Vancouver, British Columbia – August 12, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company developing [...]

NeutriSci International Inc., an innovative technology company developing products for the nutraceutical industry, announces that it will issue 2,060,534 common shares, at a deemed price of $0.05 [...]

NeutriSci International Inc. (“NeutriSci” or the “Company”) the innovator and pioneer behind neuenergy(R) is pleased to announce that it has closed on the first tranche of [...]

Vancouver, British Columbia – January 16, 2020 – NeutriSci International Inc. (“NeutriSci” or the “Company”) the innovator and pioneer behind neuenergy(R) is pleased [...]

NeutriSci International Inc. (‘NeutriSci’ or the ‘Company’) the innovator and pioneer behind neuenergy® is pleased to announce that it intends to complete a non-brokered [...]

NeutriSci International Inc. (“NeutriSci”) the innovator and pioneer behind neuenergy is pleased to announce that it has expanded its previously announced partnerships with Cryopharm [...]

VANCOUVER, British Columbia – October 5, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) is pleased to [...]

Vancouver, British Columbia – March 27, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

  VANCOUVER, B.C. – Feb. 22, 2018 (GLOBE NEWSWIRE) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) [...]

Vancouver, British Columbia – December 6, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) is pleased to [...]